http://wsw.com/webcast/rrshq23/ONCS/
La presentación de hoy, como mi ingles es tremendamente limitado, he de quedarme con los datos de la diapositiva 16 creo que son muy explicitos.
Si alguien que hable ingles bien ve algo positivo o negativo que comente please.
El que sepa tradearla se estará haciendo de oro, tremendo tobogán, como yo no tengo ni puta idea me limito a colgar este interesante articulo.
http://marketplayground.com/2013/09/12/oncosec-medical-inc-otcmktsoncs-a-presentation-of-catalysts/
Dilucion, no puedo poner el enlace voy con movil
47,8M acciones a $0,25/acción.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
Gracias fiera!!
Esto es un extracto de la dilución, significa esto que se hace sólo a inversores institucionales?
SAN DIEGO-- OncoSec Medical Inc. (OTCQB:ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $12 million of securities in a registered public offering. OncoSec has agreed to sell to institutional investors an aggregate of 47,792,000 shares of its common stock at $0.25 per share. Additionally, investors will receive warrants to purchase up to 23,896,000 shares of common stock at an exercise price of $0.35 per share for a term of four years.
The gross proceeds of the offering are expected to be approximately $12 million. Net proceeds, after deducting the placement agent’s fee and other estimated offering expenses payable by OncoSec, are expected to be approximately $11.1 million.
OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses
Eso entiendo.
«Después de nada, o después de todo/ supe que todo no era más que nada.»
Gracias Ana, si así es mucho mejor, dentro de lo malo de la dilución mejor asi.
A esperar toca.
